We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
Among a cohort of hypertensive patients in South India: 3-months follow-up study
Millions at risk from 'silent killer' as NHS campaign warns there are often 'no clues' when it comes to high blood pressure.
This professional resource outlines how providers and commissioners can reduce blood pressure in the population.
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
You may need to tell DVLA if you have high or low blood pressure - download form to inform DVLA
You must tell DVLA if you have high blood pressure and drive a bus, coach or lorry - download the correct form to let them know
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (30 January 2024) approved the medicine momelotinib (Omjjara) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or severe anaemia (a low number of red blood cells...
The NHSBT / PHE epidemiology unit, and the epidemiology of infections among blood, tissue and organ donors and recipients.
The epidemiology, symptoms, diagnosis and management of severe fever with thrombocytopaenia syndrome (SFTS).
Information about ensuring blood and blood component safety.
You can claim relief to pay no Customs Duty and VAT if you're importing therapeutic substances of human origin, blood-grouping or tissue-typing reagents, or related packaging, solvents and accessories.
Monitoring significant occupational exposures to HIV, hepatitis B and hepatitis C in healthcare workers, and advising on avoiding injuries.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).